Privia Health Group (NASDAQ:PRVA) CFO David Mountcastle Sells 6,453 Shares

Privia Health Group, Inc. (NASDAQ:PRVA) CFO David Mountcastle sold 6,453 shares of the firm’s stock in a transaction on Thursday, March 12th. The shares were sold at an average price of $21.90, for a total value of $141,320.70. Following the completion of the transaction, the chief financial officer owned 233,369 shares in the company, valued at $5,110,781.10. The trade was a 2.69% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website.

David Mountcastle also recently made the following trade(s):

• On Friday, March 13th, David Mountcastle sold 6,565 shares of Privia Health Group stock. The stock was sold at an average price of $21.52, for a total value of $141,278.80.
• On Monday, March 9th, David Mountcastle sold 5,829 shares of Privia Health Group stock. The shares were sold at an average price of $22.84, for a total transaction of $133,134.36.
• On Friday, March 6th, David Mountcastle sold 5,177 shares of Privia Health Group stock. The stock was sold at an average price of $23.15, for a total value of $119,847.55.
• On Thursday, February 26th, David Mountcastle sold 5,361 shares of Privia Health Group stock. The shares were sold at an average price of $25.00, for a total value of $134,025.00.
• On Friday, February 27th, David Mountcastle sold 7,697 shares of Privia Health Group stock. The stock was sold at an average price of $25.05, for a total transaction of $192,809.85.

Privia Health Group Price Performance

NASDAQ:PRVA opened at $21.96 on Tuesday. Privia Health Group, Inc. has a 12 month low of $18.77 and a 12 month high of $26.51. The firm has a market capitalization of $2.72 billion, a PE ratio of 129.18, a price-to-earnings-growth ratio of 1.37 and a beta of 0.82. The business’s fifty day moving average price is $22.85 and its 200 day moving average price is $23.62.

Privia Health Group (NASDAQ:PRVA) last released its quarterly earnings data on Thursday, February 26th. The company reported $0.25 earnings per share for the quarter, topping analysts’ consensus estimates of $0.04 by $0.21. The company had revenue of $541.17 million for the quarter, compared to analysts’ expectations of $516.61 million. Privia Health Group had a net margin of 1.08% and a return on equity of 3.06%. The firm’s revenue for the quarter was up 17.4% on a year-over-year basis. During the same quarter last year, the company earned $0.21 earnings per share. As a group, equities analysts anticipate that Privia Health Group, Inc. will post 0.14 EPS for the current year.

Analyst Upgrades and Downgrades

A number of brokerages recently commented on PRVA. Stephens reissued an “overweight” rating and issued a $32.00 price objective on shares of Privia Health Group in a research note on Thursday, December 4th. Royal Bank Of Canada initiated coverage on shares of Privia Health Group in a report on Friday, January 9th. They issued an “outperform” rating and a $31.00 price target on the stock. Canaccord Genuity Group increased their price target on shares of Privia Health Group from $34.00 to $35.00 and gave the company a “buy” rating in a research report on Friday, February 27th. Wolfe Research set a $31.00 price objective on shares of Privia Health Group in a research note on Tuesday, January 6th. Finally, Jefferies Financial Group restated a “buy” rating and set a $32.00 price objective on shares of Privia Health Group in a research report on Thursday, February 26th. Thirteen research analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $31.00.

Hedge Funds Weigh In On Privia Health Group

Institutional investors have recently added to or reduced their stakes in the company. Great Lakes Advisors LLC purchased a new position in Privia Health Group in the third quarter valued at about $4,487,000. Advantage Alpha Capital Partners LP purchased a new stake in Privia Health Group during the 2nd quarter worth approximately $3,941,000. Hsbc Holdings PLC raised its position in shares of Privia Health Group by 69.2% in the 2nd quarter. Hsbc Holdings PLC now owns 113,718 shares of the company’s stock valued at $2,549,000 after purchasing an additional 46,526 shares in the last quarter. Edgestream Partners L.P. acquired a new position in shares of Privia Health Group in the 2nd quarter valued at approximately $2,209,000. Finally, ArrowMark Colorado Holdings LLC purchased a new position in shares of Privia Health Group during the 3rd quarter valued at approximately $8,750,000. Institutional investors and hedge funds own 94.48% of the company’s stock.

Privia Health Group Company Profile

Privia Health Group (NASDAQ: PRVA) is a physician enablement company that partners with independent physicians, medical groups and health systems to transform the delivery of patient care. Through a clinically integrated network and a proprietary technology platform, the company supports providers in managing population health, delivering coordinated care and optimizing financial performance under both fee-for-service and value-based reimbursement models.

Founded in 2016 and headquartered in McLean, Virginia, Privia Health has rapidly expanded its footprint to serve multiple metropolitan markets across the United States.